Carboxyalkyl Chitosan Patent Application
Summary
The USPTO has published a patent application (US20260078203A1) for a carboxyalkyl chitosan. The application details compositions, manufacturing processes, and therapeutic applications in areas such as rheumatology, ophthalmology, and dermatology. The filing date was November 26, 2025.
What changed
This document is a published patent application from the USPTO concerning a carboxyalkyl chitosan. The application, identified as US20260078203A1, details the composition, manufacturing process, and potential therapeutic applications of the substance. These applications span various medical and cosmetic fields, including rheumatology, ophthalmology, aesthetic medicine, plastic surgery, dermatology, and cosmetics.
As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and medical device companies involved in research and development within these therapeutic areas. The filing date for this application was November 26, 2025.
Archived snapshot
Mar 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Carboxyalkyl Chitosan
Application US20260078203A1 Kind: A1 Mar 19, 2026
Inventors
Mickaël Chausson, Pierre Douette, Sandrine Emilia Gautier, Philippe Vaesen, Houtaï Choumane, Guillermo Rocasalbas
Abstract
The present invention relates to a carboxyalkyl chitosan, compositions comprising same, a process for manufacturing same, and various applications thereof, in particular in the field of therapy, rheumatology, ophthalmology, aesthetic medicine, plastic surgery, internal surgery, dermatology or cosmetics.
CPC Classifications
C08B 37/003 A61K 9/0019 A61K 31/722 A61L 27/20 A61P 19/02 A61L 2400/06 A61L 2430/06
Filing Date
2025-11-26
Application No.
19402291
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.